Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
In the realm of modern pharmaceuticals, chirality—the 'handedness' of molecules—is a cornerstone of drug design and efficacy. Methyl D-(-)-4-hydroxy-phenylglycinate (CAS 37763-23-8) emerges as a compound of significant importance in chiral synthesis, serving as a key pharmaceutical intermediate for a variety of applications. Its precise stereochemistry makes it an invaluable component for manufacturers and researchers aiming to develop stereospecific drugs.
The primary significance of Methyl D-(-)-4-hydroxy-phenylglycinate in chiral synthesis stems from its application in the production of antibiotics. As a critical intermediate for penicillin and cephalosporins, its specific enantiomeric form ensures the correct three-dimensional structure required for these drugs to effectively interact with their biological targets. The development of chiral drugs demands intermediates that not only possess the correct functional groups but also the precise stereochemical configuration. This compound fits that requirement perfectly, enabling the synthesis of highly potent and selective therapeutic agents.
Beyond established antibiotic synthesis, Methyl D-(-)-4-hydroxy-phenylglycinate is instrumental in the broader field of chiral drugs synthesis. The pharmaceutical industry increasingly focuses on developing enantiomerically pure drugs to maximize therapeutic benefits while minimizing potential side effects associated with inactive or harmful enantiomers. As a versatile chiral building block, this intermediate allows chemists to construct complex chiral molecules with high enantiomeric excess (ee). Researchers in pharmaceutical R&D often seek reliable suppliers to buy this compound for exploring novel drug candidates and optimizing existing synthetic pathways.
The availability of high-purity Methyl D-(-)-4-hydroxy-phenylglycinate from reputable manufacturers, particularly in China, is crucial for driving innovation in chiral synthesis. Its consistent quality and well-defined stereochemistry simplify complex synthetic routes and contribute to the overall efficiency of drug development processes. For companies looking to procure this intermediate, understanding its role in chiral synthesis underscores its value. We invite you to inquire about the purchase of Methyl D-(-)-4-hydroxy-phenylglycinate, to discuss your chiral synthesis requirements, and to experience the reliability of our supply chain as a leading manufacturer dedicated to advancing pharmaceutical science.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
